KSE - Delayed Quote KRW

Whan In Pharm Co.,Ltd. (016580.KS)

Compare
12,070.00
+60.00
+(0.50%)
At close: January 17 at 3:30:30 PM GMT+9

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 68.11B
Earnings --
Q2'23
Q3'23
Q2'24
Q3'24
0
20B
40B
60B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

21,000.00
21,000.00 Average
12,070.00 Current
21,000.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts ----11
Avg. Estimate 001,3121,323
Low Estimate 001,3121,323
High Estimate 001,3121,323
Year Ago EPS ----1,9501,312

Revenue Estimate

Currency in KRW Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1111
Avg. Estimate 66.9B64.9B260.3B276B
Low Estimate 66.9B64.9B260.3B276B
High Estimate 66.9B64.9B260.3B276B
Year Ago Sales ----230.39B260.3B
Sales Growth (year/est) ----12.98%6.03%

Earnings History

Currency in KRW 6/30/2024
EPS Est. --
EPS Actual 407
Difference --
Surprise % --

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 001,3121,323
7 Days Ago 001,3941,505
30 Days Ago 001,3941,505
60 Days Ago 001,3941,505
90 Days Ago 001,3941,505

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days ----11
Up Last 30 Days ----11
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
016580.KS -----32.72%0.84%
S&P 500 9.26%11.36%13.91%13.52%

Related Tickers